FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079393363> ?p ?o ?g. }

• W2079393363 endingPage "273" @default.
• W2079393363 startingPage "269" @default.
• W2079393363 abstract "Atherosclerosis has been considered to be an inflammatory process. In addition to its lipid-lowering properties, statin has been shown to decrease the concentrations of inflammatory markers resulting in reduction of cardiovascular events. Emerging data suggest that withdrawal of statin might be associated with increased cardiac events. The mechanism for this phenomenon, however, is still unclear. We investigated whether acute termination of statin treatment could result in rebound of inflammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-6), in patients with hyperlipidemia. Seventeen patients (11 men and 6 women, mean age 51 ± 7 years) with hyperlipidemia were given 40 mg/day of pravastatin for 6 weeks. The concentrations of plasma CRP and IL-6 were evaluated before receiving the statin therapy, immediately after 6 weeks of pravastatin therapy, and at days 1, 3 and 7 after withdrawal of pravastatin therapy. The lipid profile was also evaluated at baseline, 6 weeks of therapy, and at day 7 after terminating pravastatin. Pravastatin therapy induced significant reductions in total cholesterol (TC, 6.88 ± 0.36 vs. 5.27 ± 0.23 mmol/l, p < 0.01), low-density lipoprotein (LDL) cholesterol (4.28 ± 0.25 vs. 3.06 ± 0.14 mmol/l, p < 0.01), CRP (0.28 ± 0.16 vs. 0.20 ± 0.08 mg/l, p < 0.01), and IL-6 (8.4 ± 0.6 vs. 6.7 ± 0.4 pg/dl, p < 0.01). Although the TC and LDL-cholesterol did not change during the 7-day period after withdrawal of pravastatin therapy, the concentrations of CRP and IL-6 increased at day 3 (CRP: 0.20 ± 0.08 vs. 0.27 ± 0.12 mg/l, and IL-6: 6.7 ± 0.4 vs. 7.7 ± 0.6 pg/dl, p < 0.05 respectively) and at day 7 (CRP: 0.20 ± 0.08 vs. 0.30 ± 0.14 mg/l, and IL-6: 6.7 ± 0.4 vs. 8.7 ± 0.8pg/dl, p < 0.01 respectively) after withdrawal of pravastatin therapy. No correlation between increase of CRP as well as IL-6 and small changes of LDL-cholesterol concentrations was found after withdrawal of pravastatin therapy at day 7 (r = − 0.021 and r = − 0.044 respectively, p > 0.05 respectively). 6 weeks after pravastatin therapy could significant modify the lipid profile and decrease the inflammatory markers including CRP and IL-6 in patients with hyperlididemia. Moreover, statin therapy discontinuation could induce a rebound phenomenon of inflammatory response representing an increase in some inflammatory markers, which is independent of changes of lipid parameters." @default.
• W2079393363 created "2016-06-24" @default.
• W2079393363 creator A5001989498 @default.
• W2079393363 creator A5018863416 @default.
• W2079393363 creator A5042484728 @default.
• W2079393363 creator A5052574336 @default.
• W2079393363 creator A5060511746 @default.
• W2079393363 creator A5065363687 @default.
• W2079393363 creator A5075662908 @default.
• W2079393363 creator A5087950385 @default.
• W2079393363 creator A5088338925 @default.
• W2079393363 date "2006-04-01" @default.
• W2079393363 modified "2023-09-25" @default.
• W2079393363 title "Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia" @default.
• W2079393363 cites W1964362321 @default.
• W2079393363 cites W1966038161 @default.
• W2079393363 cites W1982290971 @default.
• W2079393363 cites W1999103202 @default.
• W2079393363 cites W1999788580 @default.
• W2079393363 cites W2017326852 @default.
• W2079393363 cites W2045725665 @default.
• W2079393363 cites W2050765392 @default.
• W2079393363 cites W2050888034 @default.
• W2079393363 cites W2062423902 @default.
• W2079393363 cites W2076372308 @default.
• W2079393363 cites W2077241506 @default.
• W2079393363 cites W2082127904 @default.
• W2079393363 cites W2104776081 @default.
• W2079393363 cites W2108041121 @default.
• W2079393363 cites W2111419779 @default.
• W2079393363 cites W2120221873 @default.
• W2079393363 cites W2124728065 @default.
• W2079393363 cites W2139422038 @default.
• W2079393363 cites W2147912194 @default.
• W2079393363 cites W2151725999 @default.
• W2079393363 cites W2161821089 @default.
• W2079393363 cites W2318554725 @default.
• W2079393363 cites W2324841714 @default.
• W2079393363 doi "https://doi.org/10.1016/j.cca.2005.10.021" @default.
• W2079393363 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16343471" @default.
• W2079393363 hasPublicationYear "2006" @default.
• W2079393363 type Work @default.
• W2079393363 sameAs 2079393363 @default.
• W2079393363 citedByCount "41" @default.
• W2079393363 countsByYear W20793933632012 @default.
• W2079393363 countsByYear W20793933632013 @default.
• W2079393363 countsByYear W20793933632014 @default.
• W2079393363 countsByYear W20793933632015 @default.
• W2079393363 countsByYear W20793933632016 @default.
• W2079393363 countsByYear W20793933632017 @default.
• W2079393363 countsByYear W20793933632019 @default.
• W2079393363 countsByYear W20793933632020 @default.
• W2079393363 countsByYear W20793933632023 @default.
• W2079393363 crossrefType "journal-article" @default.
• W2079393363 hasAuthorship W2079393363A5001989498 @default.
• W2079393363 hasAuthorship W2079393363A5018863416 @default.
• W2079393363 hasAuthorship W2079393363A5042484728 @default.
• W2079393363 hasAuthorship W2079393363A5052574336 @default.
• W2079393363 hasAuthorship W2079393363A5060511746 @default.
• W2079393363 hasAuthorship W2079393363A5065363687 @default.
• W2079393363 hasAuthorship W2079393363A5075662908 @default.
• W2079393363 hasAuthorship W2079393363A5087950385 @default.
• W2079393363 hasAuthorship W2079393363A5088338925 @default.
• W2079393363 hasConcept C126322002 @default.
• W2079393363 hasConcept C134018914 @default.
• W2079393363 hasConcept C2776839432 @default.
• W2079393363 hasConcept C2776914184 @default.
• W2079393363 hasConcept C2778163477 @default.
• W2079393363 hasConcept C2778270857 @default.
• W2079393363 hasConcept C2779091943 @default.
• W2079393363 hasConcept C2779519902 @default.
• W2079393363 hasConcept C2781195455 @default.
• W2079393363 hasConcept C555293320 @default.
• W2079393363 hasConcept C71924100 @default.
• W2079393363 hasConcept C90924648 @default.
• W2079393363 hasConceptScore W2079393363C126322002 @default.
• W2079393363 hasConceptScore W2079393363C134018914 @default.
• W2079393363 hasConceptScore W2079393363C2776839432 @default.
• W2079393363 hasConceptScore W2079393363C2776914184 @default.
• W2079393363 hasConceptScore W2079393363C2778163477 @default.
• W2079393363 hasConceptScore W2079393363C2778270857 @default.
• W2079393363 hasConceptScore W2079393363C2779091943 @default.
• W2079393363 hasConceptScore W2079393363C2779519902 @default.
• W2079393363 hasConceptScore W2079393363C2781195455 @default.
• W2079393363 hasConceptScore W2079393363C555293320 @default.
• W2079393363 hasConceptScore W2079393363C71924100 @default.
• W2079393363 hasConceptScore W2079393363C90924648 @default.
• W2079393363 hasIssue "1-2" @default.
• W2079393363 hasLocation W20793933631 @default.
• W2079393363 hasLocation W20793933632 @default.
• W2079393363 hasOpenAccess W2079393363 @default.
• W2079393363 hasPrimaryLocation W20793933631 @default.
• W2079393363 hasRelatedWork W1982290971 @default.
• W2079393363 hasRelatedWork W1982298768 @default.
• W2079393363 hasRelatedWork W2003980493 @default.
• W2079393363 hasRelatedWork W2035331946 @default.
• W2079393363 hasRelatedWork W2073895456 @default.
• W2079393363 hasRelatedWork W2079393363 @default.

• next